ROGER KORNU M.D. NPI 1841386349

NPI Details

Roger Kornu, M.D. is a rheumatology internal medicine in Tustin, CA with 27 years of experience. The provider is an internist who treats diseases of joints, muscle, bones and tendons. This specialist diagnoses and treats arthritis, back pain, muscle strains, common athletic injuries and collagen diseases. Roger Kornu, M.D. NPI is 1841386349. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL SCHOOL AT DALLAS
Graduation Year:1999

The provider's business location address is:

2552 WALNUT AVE STE 200
TUSTIN, CA
ZIP 92780-983
Phone: (714) 406-4461
Fax: (714) 669-9790

The NPI 1841386349 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, tocilizumab, 1 mg (HCPCS:J3262)
• Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0717)
• Injection, golimumab, 1 mg, for intravenous use (HCPCS:J1602)
• Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0129)
• Injection, romosozumab-aqqg, 1 mg (HCPCS:J3111)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Telephone medical discussion with physician, 5-10 minutes (HCPCS:99441)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Aspiration and/or injection of fluid from large joint (HCPCS:20610)
• Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
• Injection, methylprednisolone acetate, 40 mg (HCPCS:J1030)
• Injection, methylprednisolone acetate, 80 mg (HCPCS:J1040)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic (HCPCS:G2012)

The enumeration date for this NPI number is 10/4/2006 and was last updated on 11/5/2024.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: